Pathogenesis and Symptoms T. cruzi is primarily transmitted to humans and other mammals by Triatomine insect vectors, also known as "kissing bugs." The parasite infects cells and tissues including muscle and nervous tissue. In the acute phase shortly after transmission, symptoms may include swelling of the eyelids, fever, headaches, and enlargement of the liver and spleen. However, most acute...
Another area of focus in Chagas Disease Treatment is the development of combination therapies. Since the parasite can develop resistance to single drugs, combining different medications with complementary mechanisms of action may increase treatment effectiveness. Some studies have shown that combination therapies involving benznidazole or nifurtimox with other drugs, such as antifungal agents...
Key players operating in the Chagas Disease Treatment Market Size are Huiheng Medical Inc., Top Grade Healthcare, Varian Medical Systems, Accuray Inc., Hitachi, Shinva Medical Instrument Co. Ltd., and Elekta AB.The growing demand for drugs to treat Chagas disease is expected to drive the market growth during the forecast period. According to the WHO, 10 million people are estimated to...
Most people who become infected with T. cruzi do not experience symptoms during the initial acute phase of infection. For those who do show symptoms in the acute phase, treatment options include medications such as benznidazole or nifurtimox. These treatments can clear the parasite and cure the infection if given early enough. During the acute phase, which lasts up to 90 days after infection,...